Literature DB >> 2614113

[The preserving effects of bronchial arteries and pulmonary nerves at radical esophagectomy on cardio-respiratory functions in dogs].

I Shima.   

Abstract

In order to investigate the relationship between postoperative pulmonary complications and radical esophagectomy for esophageal cancer including the merit of preservation of the bronchial arteries and pulmonary nerves, changes in cardio-respiratory functions were studied perioperatively by using 28 dogs. Four groups of the experiments were designed as follows. Group A, ablation around the esophagus and trachea including upper mediastinal and cervical lymphnode dissection; Group B, Group A with preserving bronchial arteries and pulmonary nerves; Group C, Group A with postoperative hydration of crystalloid; Group D, Group B with postoperative hydration of crystalloid. The following results were obtained. 1. PAP and PWP in Group A showed marked elevations by 3 hours after surgery. 2. Intravenous hydration of crystalloid resulted in remarkable increase in EVLW in Group A, while the slight changes were observed in Group B. 3. In Group A, CL were decreased, and then RL and pulmonary shunt ratio were significantly increased postoperatively as compared with these values in Group B. 4. In microscopic findings of the lung, there were no significant differences between Group A and Group B. On the other hand, atelectasis, congestion and perivascular edema were noted in groups with the hydration. These results suggest radical esophagectomy preserving bronchial arteries and pulmonary nerves play an important role in the prevention of postoperative pulmonary complications.

Entities:  

Mesh:

Year:  1989        PMID: 2614113

Source DB:  PubMed          Journal:  Nihon Kyobu Geka Gakkai Zasshi        ISSN: 0369-4739


  1 in total

1.  Intrapulmonary right-left shunts in Guillain-Barré syndrome with severe dysautonomia.

Authors:  Marek Sykora; Jennifer Diedler; Werner Hacke; Roland Veltkamp
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.